Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes

The identification of new predictive biomarkers and therapeutic target for tailored therapy in breast cancer onset and progression is an interesting challenge. OLR-1 gene encodes the cell membrane receptor LOX-1 (lectin-like oxidized low-density lipoprotein receptor). We have recently identified a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Pucci, Sabina, Polidoro, Chiara, Greggi, Chiara, Amati, Francesca, Morini, Elena, Murdocca, Michela, Biancolella, Michela, Orlandi, Augusto, Sangiuolo, Federica, Novelli, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362207/
https://www.ncbi.nlm.nih.gov/pubmed/30718451
http://dx.doi.org/10.1038/s41419-018-1279-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362207/
https://www.ncbi.nlm.nih.gov/pubmed/30718451
http://dx.doi.org/10.1038/s41419-018-1279-1

Ejemplares similares